Skip to main content
Have a personal or library account? Click to login
An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension Cover

An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension

Open Access
|Nov 2012

References

  1. 1. C. W. Oakley, Primary pulmonary hypertension. Case series from the United Kingdom,.(1994) 29S-32S; DOI: 10.1378/chest.105.2_Supplement.29S.
  2. 2. B. G. Schwartz, L. A. Levine, G. Comstock, V. J. Stecher and R. A. Kloner, Cardiac uses of Phosphodiesterase-5 Inhibitors,(2012) 9-15; DOI:10.1016/j.jacc.2011.07.051.
  3. 3. G. D. Lewis, R. Shah, K. Shahzad, J. M. Camuso, P. P. Pappagianopoulos, J. Hung, A. Tawakol, R. E. Gerszten, D. M. Systrom, K. D. Bloch, M. J. Semigran, Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension,(2007) 1555-1562; DOI: 10.1161/CIRCULATIONAHA.107.716373.
  4. 4. V. Q. Chau, F. N. Salloum, N. N. Hoke, A. Abbate and R. C. Kukreja, Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway,(2011) H2272-H2279; DOI: 10.1152/ajpheart.00654.2010.
  5. 5. J. Nagendran, S. L. Archer, D. Soliman, V. Gurtu, R. Moudgil, A. Haromy, C. St Aubin, L. Webster, I. M. Rebeyka, D. B. Ross, P. E. Light, J. R. Dyck, E. D. Michelakis, Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility,(2007) 238-248; DOI: 10.1161/CIRCULATIONAHA. 106.655266.
  6. 6. L. Zhao, N. A. Mason, N. W. Morrell, B. Kojonazarov, A. Sadykov, A. Maripov, M. M. Mirrakhimov, A. Aldashev and M. R. Wilkins, Sildenafil inhibits hypoxia-induced pulmonary hypertension,(2001) 424-428; DOI: 10.1161/hc2901.093117.
  7. 7. P. Rajagopalan, A. Mazzu, C. Xia, R. Dawkins and P. Sundaresan, Effect of high-fat breakfast and moderate-fat evening meal on pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction,(2003) 260-267; DOI: 10.1177/0091270002250604.
  8. 8. A. H. Elshafeey, E. R. Bendasand O. H. Mohamed, Intranasal microemulsion of sildenafil citrate:evaluation andpharmacokinetic study in rabbits,.(2009) 361-367; DOI: 10.1208/s12249-009-9213-6.
  9. 9. A. H. Shajaei, Buccal mucosa as a route for systemic drug delivery.(1998) 15-30; http://www.ualberta.ca/~csps/JPPS1(1)/A.Shojaei/buccalreview.htm.
  10. 10. Z. Bayrak, C. Tas, U. Tasdemir, H. Erol, C. K. Ozkan, A. Sayaser and Y. Ozkan, Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers:andevaluation,(2011) 499-505; DOI: 10.1016/j.ejpb.2011.02.014.
  11. 11. S. A. Randale, C. S. Dabhi, A. R. Tekade, V. S. Belgamwar, S. G. Gattani and S. J. Surana, Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method,,(2010) 443-448; DOI: 10.1248/cpb.58.443.
  12. 12. S. Bandari, R. K. Mittapalli, R.Gannu and Y. H. Rao, Orodispersibletablets: an overview,.(2008) 2-11; DOI: 10.4103/0973-8398.41557.
  13. 13. G. Abdelbary, C. Eouani, P. Prinderre, J. Joachim, J. Reynier and P. Piccerelle, Determination of thedisintegration profile of rapidly disintegrating tablets and correlation with oral disintegration,.(2005) 29-41; DOI:10.1016/j.ijpharm.2004.08.019.
  14. 14. J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles,,(1996) 64-74.
  15. 15. »Declaration of Helsinki.« As amended by the 59th World Medical Assembly (WMA). World Medical Association, Seoul, South Korea, October 2008. Available at: http://www.wma.net/e/ethicsunit/helsinki.htm.
  16. 16. V. P. Shah, K. K. Midha, S. Dighe, I. J. McGilveray, J. P. Skelly, A. Yacobi, T. Layloff, C. T. Viswanathan, C. E. Cook and R. D. McDowall, Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report,(1991) 249-255; DOI: 10.1002/jps.2600810324.
  17. 17. A. P. Simonelli, S. C. Mehta, W. I. Higuchi. Dissolution rates of high energy polyvinylpyrrolidone-sulfathiazole coprecipitates,(1969) 538-549; DOI: 10.1002/jps.2600580503.
  18. 18. O. I. Corrigan, Mechanisms of dissolution of fast release solid dispersions.(1985) 697-724; DOI: 10.3109/03639048509056896.
  19. 19. M. Newa, K. H. Bhandari, D. X. Li, T. H. Kwon, J. A. Kim, B. K. Yoo, J. S. Woo, W. S. Lyoo, C. S. Yong, H. G. Choi, Preparation, characterization andevaluation of ibuprofen binary solid dispersions with Poloxamer 188,(2007) 228-237; DOI: 10.1016/j.ijpharm.2007. 05.031.
  20. 20. N. Passerini, M. L. Gonzalez-Rodriguez, C. Cavallari, L. Rodriguez and B. Albertini, Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation,(2002) 71-78; DOI: 10.1016/S0928-0987(01)00210-X.
  21. 21. P. P. Shah and R. C. Mashru, Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
  22. (2008) 494-500; DOI: 10.1208/s12249-008-9066-4. 22. S. Khan, H. Batchelor, P. Hanson, Y. Perrie and A. R. Mohammed, Physicochemical characterization, drug polymer dissolution andevaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000,(2011) 4281-4294; DOI: 10.1002/jps.22613.
  23. 23. A. Quadir and K. Kolter, A comparative study of current superdisintegrants,2006
  24. 24. R. Chandrasekhar, Z. Hassan, F. Alhusban, A. M. Smith and A. R. Mohammed, The role of formulation excipients in the development of lyophilized fast-disintegrating tablets,(2009) 119-129; DOI: 10.1016/j.ejpb.2008.11.011.
  25. 25. W. L. Chiou and S. Riegelman, Pharmaceutical application of solid dispersion system,(1971) 1281-1302; DOI: 10.1002/jps.2600600902.
  26. 26. R. A. Shoukri, I. S. Ahmed and R. N. Shamma,andevaluation of nimesulide lyophilized orally disintegrating tablets,(2009) 162-171; DOI: 10.1016/j.ejpb.2009.04.005.
  27. 27. V. B. Djagny, Z. Wang and S. Xu, Gelatin: A valuable protein for food and pharmaceutical industries: Review,(2001) 481-492; DOI: 10.1080/20014091091904.
  28. 28. P. J. Dawson and D. J. Hockley, Scanning electron microscopy of freeze-dried preparations: relationship of morphology to freeze-drying parameters,(1991) 185-192.
  29. 29. D. J. van Drooge, W. L. J. Hinrichs and H. W. Frijlink, Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent,(2004) 713-725; DOI: 10.1002/jps.10590.
  30. 30. A. A. Mahmoud and S. Salah, Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets,(2011) 1-8; DOI:10.3109/03639045.2011.625949.
  31. 31. REVATIO - sildenafil citrate tablet, film coatedPfizer Labs http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfmfiarchiveid=10206.
  32. 32. A. Abdelbary, A. H. Elshafeeyand G. Zidan, Comparative effects of different cellulosic-based directly compressed orodispersable tablets on oral bioavailability of famotidine, Carb(2009) 799-806; DOI:10.1016/j.carbpol.2009.02.030.
  33. 33. M. M. Rawas-Qalaji, F. E. Simons and K. J.Simons, Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis,(2006) 398-403; DOI:10.1016/j.jaci.2005.12.1310.
  34. 34. G. V. Betageri and K. R. Makarla, Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques,(1995) 155-160; DOI: 10.1016/0378-5173(95) 04114-1.
DOI: https://doi.org/10.2478/v10007-012-0027-9 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian, Slovenian
Page range: 411 - 432
Published on: Nov 6, 2012
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2012 Reham Zayed, Amany O. Kamel, Marwa Shukr, Abd El-Hamid El-Shamy, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.